Association between the Khorana score and pulmonary embolism risk in patients with advanced stage lung cancer.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The Khorana score may help physicians to identify patients at high risk of Pulmonary embolism (PE) and decide who is eligible for thromboprophylaxis, however, its role in lung cancer patients remains unclear.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Respir J

Title: The clinical respiratory journal

Publisher: Wiley

ISSN (Electronic): 1752-699X

ISSN (Print): 1752-6981

Publication date (Electronic): Jan 2020

Volume: 14

Issue: 1

Affiliations

[1 ] Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

[2 ] Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.

[3 ] Department of Neurology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

[4 ] Clinic of Chest diseases, Immunology and Allergology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

[5 ] Centre of Pulmonology and Allergology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Article

DOI: 10.1111/crj.13092

PubMed ID: 31585027

SO-VID: 664e4211-6191-49fb-8b88-75d2e87a7968

History

Keywords: chemotherapy,lung cancer,pulmonary embolism,risk assessment

Data availability:

Keywords: chemotherapy, lung cancer, pulmonary embolism, risk assessment

Comments

Comment on this article

scite_

Cited by 3

See all cited by